Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1


Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2024 financial results on Wednesday, May 1, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Date:

 

Wednesday, May 1, 2024

 

Time:

 

8 a.m. ET

 

Webcast:

 

https://www.webcaster4.com/Webcast/Page/2883/49631

 

Participant Event Dial-in:

 

+1 (888) 506-0062 (North America)

+1 (973) 528-0011 (International)

 

Participant Access Code:

 

357966

 

Replay Dial-in:

 

+1 (877) 481-4010 (North America)

+1 (919) 882-2331 (International)

 

Replay Passcode:

 

49631 (replay available until May 15, 2024)

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world ? from birth through every phase of life. Its comprehensive portfolio of approximately 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with approximately 13,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on X, LinkedIn, Facebook and Instagram.

© 2024 Bausch + Lomb.


These press releases may also interest you

at 12:23
Fifty-eight percent of bankers would take action to reduce costs or increase revenue elsewhere even if exempt under a new regulatory proposal to restrict overdraft fees, according to a survey of nearly 500 financial executives released today. In a...

at 12:20
Smallstep Labs, a pioneer in streamlining secure device identity and champion of the Zero Trust approach to security, unveiled market data that shows an impressive 78% of the Fortune 100 companies actively engage with Smallstep's open source...

at 12:20
Aubex Therapeutics Inc., a pioneering biotechnology firm, announced its official launch, heralding a new era in the battle against cancer. Under the guidance of Board Member and Interim CEO, Jeffrey Glazer, Aubex's initial program is focused on novel...

at 12:18
AdGPT, the world's first fully automated ad creative tool for SMBs, today announced its launch out of stealth. The platform enables SMBs to create high-finish ads, without any previous advertising experience, that are optimized for digital...

at 12:15
Affini-T Therapeutics, Inc., a precision immunotherapy company unlocking the power of T cells against oncogenic driver mutations, today announced that data from its preclinical gene edited HLA-A*11:01 KRAS G12D (AFNT-212) and HLA-A*02:01 TP53 R175H T...

at 12:15
H2scan (www.h2scan.com), a leader in solid-state hydrogen sensing solutions, proudly announces a new milestone: more than 1.3 billion hours of field-proven service across a broad range of applications. This achievement includes 700 million hours in...



News published on and distributed by: